USPTO Grants Divisional Patent to Integral BioSystems for its NanoM™ Drug Delivery Platform
The USPTO has issued a Divisional Patent for Integral BioSystems’ NanoM™, the firm’s flagship sustained release drug formulation platform BEDFORD, MA, US, February 21, 2019 /EINPresswire.com/ -- Boston-area drug development firm Integral BioSystems has …